Aviv Regev

Education Regev studied at the Adi Lautman Interdisciplinary Program for Outstanding Students of Tel Aviv University, where she completed her PhD under the supervision of Eva Jablonka, and Ehud Shapiro.

Career and research In 2020, Regev became the head and executive vice president of Genentech Research and Early Development, based in South San Francisco, and a member of the extended corporate executive committee of Roche. includes work on gene expression (with Eran Segal and David Botstein), and the use of π-calculus to represent biochemical processes. Regev's team has been a leading pioneer of single-cell genomics experimental and computational methods. In 2014, she pitched the idea of the creation of Human Cell Atlas, a project to describe all cell types in the human body. Regev founded the Human Cell Atlas together with Sarah Teichmann along with collaborators all over the world.

Single Cell Genomics Regev's lab pioneered the development and application of many of the key experimental and computational advances for single cell and spatial genomics, especially single cell RNA-Seq (scRNA-seq).

Fellowships and memberships

Associate member of the European Molecular Biology Organization in 2024

Foreign member of the Royal Society

Elected to the American Academy of Arts and Sciences, 2022

Fellow of the American Association for Cancer Research (AACR) (2021)

Helmholtz Fellow (2020),

Member of the US National Academy of Medicine (NAM, elected 2020)

Member of the US National Academy of Sciences (NAS, elected 2019)

Fellow of the International Society of Computational Biology (ISCB) (2017)

Awards and honors Meyenburg Prize for her outstanding achievements in cancer research (2026)

Dickson Prize in Science, 2025

William B. Coley Award for Distinguished Research in Basic and Tumor Immunology, 2025

Sune Bergström Award, 2025

Shai Shacknai Memorial Prize and Lectureship in Immunology and Cancer Research, 2024

25th L'Oréal-UNESCO For Women in Science Awards (Laureate for North America), 2023

Nakasone Award from the Human Frontiers Science Program (2022)

Honorary doctorate, ETH Zurich (2021)

Ernst Schering Prize (2021)

James Prize in Science and Technology Integration, National Academy of Sciences (2021)

Vanderbilt Prize (2021)

25th Keio Medical Science Prize in 2020

Lurie Prize from the Foundation for the NIH (FNIH) (2020)

Jonathan Kraft Prize from Massachusetts General Hospital (2020)

FASEB Excellence in Science Mid-Career Investigator Award (2019)

Served on the Life Sciences jury for the Infosys Prize in 2018.

Paul Marks Prize for Cancer Research (2017)

ISCB Innovator Award in 2017

Earl and Thressa Stadtman Scholar Award from the American Society of Biochemistry and Molecular Biology (ASBMB) (2014)

Burroughs Wellcome Fund Career Award

NIH Director's Pioneer Award, 2008

Overton Prize in 2008 for "outstanding accomplishment to a scientist in the early to mid stage of his or her career".

Keynote address at ISSCR 2026 Annual Meeting in Montréal, 2026

National Academy of Medicine Annual Meeting Keynote, 2025

Streisinger Memorial Lecture, 2025

TED AI 2023 Talk: Can AI Help Develop New Medicines

Anderson Lecture, University of Virginia, 2022

AACR-Irving Weinstein Foundation Distinguished Lecture (2021)

Mendel Lecture, European Society of Human Genetics (2020) Weatherall Lecture, University Oxford, UK (2018) Harvey Lecture, Harvey Society, New York (2018) McCormick Lecture, Stanford University (2018)